论文部分内容阅读
目的观察患者教育对肾病综合征患者对疾病及药物治疗认知程度的影响,以及其能否提高患者对临床药师的满意度。方法将84例肾病综合征患者随机分为对照组40例和试验组44例。对照组予以肾病综合征的常规治疗,试验组在常规治疗的基础上,予以临床药师个体化的患者教育。随访3个月,用调查问卷法,比较2组患者对疾病及药物治疗认知程度有无差异,并比较试验组在患者教育前后对临床药师满意程度有无差异。结果患者教育后,试验组和对照组对疾病及药物治疗基本知识得分分别为(2.37±0.72),(1.59±0.64)分,差异有统计学意义(P<0.05)。患者教育后,听说过临床药师的患者百分数为95.35%、对临床药师工作职责有所了解的患者百分数为56.10%、认为临床药师对自身病情有帮助的患者百分数为90.00%,均明显高于患者教育前的13.95%,2.44%和27.50%,差异有统计学意义(P<0.05)。Logistic回归分析显示,年龄增加、学历高为降低糖皮质激素依从性的危险因素。结论临床药师患者教育能提高肾病综合征患者对疾病及药物治疗的认识程度,同时提高患者对临床药师的满意度。
Objective To observe the influence of patient education on the cognition of disease and drug therapy in patients with nephrotic syndrome and whether it can improve patients’ satisfaction with clinical pharmacists. Methods Eighty-four patients with nephrotic syndrome were randomly divided into control group (n = 40) and experimental group (n = 44). The control group was given routine treatment of nephrotic syndrome, the experimental group on the basis of routine treatment, clinical pharmacists individualized patient education. After 3 months of follow-up, questionnaire method was used to compare the difference of cognitive level between the two groups in disease and drug treatment, and to compare the satisfaction level of clinical pharmacist before and after the patient’s education in the experimental group. Results After the patients were educated, the scores of basic knowledge of disease and drug treatment in the experimental group and the control group were (2.37 ± 0.72) and (1.59 ± 0.64) points respectively, the difference was statistically significant (P <0.05). Patient education, I heard that the percentage of clinical pharmacists was 95.35%, the percentage of patients who knew about the duties of clinical pharmacists was 56.10%, and the percentage of patients who considered clinical pharmacists helpful for their condition was significantly higher than that of 90.00% Patients before education 13.95%, 2.44% and 27.50%, the difference was statistically significant (P <0.05). Logistic regression analysis showed that age increased, high education as a risk factor to reduce glucocorticoid compliance. Conclusion Clinical pharmacist patient education can improve the degree of awareness of patients with nephrotic syndrome on disease and drug treatment, and improve patient satisfaction with clinical pharmacists.